NEW AMBRX BIOPHARMA INC (AMAM)

US6418711080 - Common Stock

28  +0.02 (+0.07%)

After market: 28 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
5.68M7.40M7.46M13.67M10.31M
Minority Interest Expense
N/A0.00210.00K1.30M2.25M
Operating Expenses
94.01M74.14M71.88M26.79M32.78M
Research and Development
57.11M31.25M53.61M19.19M25.14M
Selling, General, and Administrative Expenses
36.91M42.90M18.27M7.60M7.64M
Operating Income
-88.32M-66.74M-64.42M-13.12M-22.47M
Interest Income/Expense
6.22M370.00K-3.90M30.00K200.00K
Other Income/Expense
230.00K-30.00K40.00K-4.75M-40.00K
Non Recurring Items
0.00-9.66MN/AN/AN/A
Income Before Taxes
-81.88M-76.06M-68.29M-17.84M-22.32M
Income Tax
750.00K1.94M0.000.000.00
Net Income
-82.63M-78.00M-68.08M-16.54M-20.06M
EBITDA
-86.52M-64.94M-62.27M-11.18M-20.42M
 
Per Share Data
EPS Diluted Total Ops
-0.57-0.29-0.25-0.06-0.08
 
Statistics
Profit Margin
-1454.75%-1054.05%-912.60%-120.99%-194.57%
Operating Profit Margin
-1554.93%-901.89%-863.54%-95.98%-217.94%

All data in USD

Charts